71773-050-05 : NDC 2026 Code

71773-050-05 : Eravacycline ( Xerava )

Additionally :

You can get information about “71773-050-05” NDC code in 71773-050-05 in HTML format

HTML | 71773-050-05 in TXT (Plain Text) format

TXT | 71773-050-05 in PDF (Portable Document Format)

PDF | 71773-050-05 in XML format

XML formats.

NDC Code : 71773-050-05 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71773-050-05",
    "PackageDescription": "1 VIAL, GLASS in 1 CARTON (71773-050-05)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
    "NDC11Code": "71773-0050-05",
    "ProductNDC": "71773-050",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Xerava",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Eravacycline",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20180910",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA211109",
    "LabelerName": "Tetraphase Pharmaceuticals, Inc.",
    "SubstanceName": "ERAVACYCLINE DIHYDROCHLORIDE",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Tetracycline-class Antibacterial [EPC], Tetracyclines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-09-26",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20180910",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}